Sign up to save your podcasts
Or
Share Why Does PrEP Use Lag in Cisgender Women?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Why Does PrEP Use Lag in Cisgender Women?
How will new study results inform HIV prevention in the US and globally? JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Jeanne Marrazzo, MD, MPH, director of NIAID, discuss these study findings and more. Related Content:
- HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women
View all episodes
By JAMA Network
4.6
162162 ratings
How will new study results inform HIV prevention in the US and globally? JAMA Deputy Editor Preeti Malani, MD, MSJ, and author Jeanne Marrazzo, MD, MPH, director of NIAID, discuss these study findings and more. Related Content:
- HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women
More shows like Healthy Dialogue
View all
Fresh Air
38,216 Listeners
Hidden Brain
43,608 Listeners
The Moth
27,046 Listeners
JAMA Editors' Summary
135 Listeners
NEJM This Week
319 Listeners
Emergency Medicine Cases
543 Listeners
AFP: American Family Physician Podcast
700 Listeners
JAMA Clinical Reviews
505 Listeners
Science Friday
6,464 Listeners
Mayo Clinic Talks
304 Listeners
Frankly Speaking About Family Medicine
269 Listeners
The Curbsiders Internal Medicine Podcast
3,364 Listeners
JAMA Psychiatry Author Interviews
22 Listeners
JAMA Neurology Author Interviews
13 Listeners
JAMA Cardiology Author Interviews
8 Listeners
JAMA Surgery Author Interviews
7 Listeners
JAMA Internal Medicine Author Interviews
20 Listeners
JAMAevidence The Rational Clinical Examination
30 Listeners
JAMA Medical News
91 Listeners
The Clinical Problem Solvers
516 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
375 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
17 Listeners
The Curious Clinicians
377 Listeners